Stocktoria

DBV Technologies S.A. DBVT

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2012-03-29

DBV Technologies S.A. statistics & valuation

Market cap$834.7M
P / B4.9×
Net margin-2607.3%
FCF margin-2159.6%
Return on capital-83.7%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-1169.50% -1415.00% -1713.50% -1987.50% -462.40% -2744.40% -2607.30% 2019202020212022202320242025
Gross margin (%)
2019202020212022202320242025
Operating margin (%)
-1162.80% -1408.70% -1727.60% -1994.90% -486.00% -2808.70% -2609.20% 2019202020212022202320242025
Return on equity (%)
-89.00% -77.60% -98.50% -49.50% -51.90% -415.80% -87.10% 2019202020212022202320242025
Shares outstanding
47.0M 54.9M 94.1M 96.4M 102.8M 139.6M 2019202020212022202320242025
Net debt ($)
-$191.8M -$195.1M -$76.8M 2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-63.30% -58.60% -66.70% -39.10% -39.70% -173.50% -62.90% 2019202020212022202320242025
Free cash flow margin (%)
-1046.50% -1493.40% -1912.30% -1164.70% -510.70% -2573.20% -2159.60% 2019202020212022202320242025
Debt / equity (×)
0.01× 0.01× 0.01× 2019202020212022202320242025
EPS ($)
-$1.78 -$1.24 -$0.76 -$1.17 -$1.05 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin-2609.2%-2808.7%-486.0%-1994.9%-1727.6%-1408.7%-1162.8%
Net margin-2607.3%-2744.4%-462.4%-1987.5%-1713.5%-1415.0%-1169.5%
FCF margin-2159.6%-2573.2%-510.7%-1164.7%-1912.3%-1493.4%-1046.5%
Return on assets-62.9%-173.5%-39.7%-39.1%-66.7%-58.6%-63.3%
Return on equity-87.1%-415.8%-51.9%-49.5%-98.5%-77.6%-89.0%
Debt / equity0.01×0.01×0.01×
Current ratio3.671.434.267.563.643.933.79

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.